1. Home
  2. NWGL vs TOVX Comparison

NWGL vs TOVX Comparison

Compare NWGL & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nature Wood Group Limited

NWGL

Nature Wood Group Limited

N/A

Current Price

$1.61

Market Cap

12.1M

Sector

N/A

ML Signal

N/A

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

N/A

Current Price

$0.24

Market Cap

10.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NWGL
TOVX
Founded
2008
2001
Country
Macau
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1M
10.1M
IPO Year
2022
2012

Fundamental Metrics

Financial Performance
Metric
NWGL
TOVX
Price
$1.61
$0.24
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
1.6M
427.7K
Earning Date
05-21-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
89.07
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.16
52 Week High
$1.82
$0.86

Technical Indicators

Market Signals
Indicator
NWGL
TOVX
Relative Strength Index (RSI) 74.59 42.01
Support Level $1.11 $0.22
Resistance Level N/A $0.26
Average True Range (ATR) 0.27 0.01
MACD 0.05 -0.00
Stochastic Oscillator 79.67 20.90

Price Performance

Historical Comparison
NWGL
TOVX

About NWGL Nature Wood Group Limited

CL Workshop Group Ltd, formerly Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

Share on Social Networks: